Mauricio Sousa

Postdoc at OHSU. Dentist-scientist fascinated with biotechnologies. Interested in oral biology and tissue engineering.

[Mauricio Sousa @Maucostasousa]

@PeterDiamandis @DrWoappi This idea of funding just projects that are basically completed (because they value tones of preliminary data) defeats the purpose of innovation.

[bioRxiv Bioengineering @bioRxiv_bioE]

Endogenous Osteocyte-Osteoclast Signaling Enables Growth Factor-Free Bone Remodeling, Drug Response, and Cancer Invasion in a Nanoscale Calcified Bone-on-a-Chip Model

https://t.co/0CrwSwfQFm
#biorxiv_bioE

[Frontiers - Bioengineering and Biotechnology @FrontBioeng]

New Research: Host-microbe-cancer interactions on-a-chip https://t.co/gZ80NfXgfA #FrontiersIn #Bioengineering #Biotechnology

[AADOCR @AADOCR]

Congratulations to Peng Chen and Mauricio Sousa, winners of the 2025 AADOCR Hatton Competition - Post-doctoral Category! 🎉🎉

https://t.co/MEFobcBTK1

#AADOCR2025 #oralhealth #dentalresearch
@OstrowOnline @OHSUKnight

[Nature Reviews Microbiology @NatureRevMicro]

New online! Human microbiome acquisition and transmission https://t.co/42Xrg43DjL

[Waggoner Lab @LabWaggoner]

Locally administered Tregs promote tissue healing by promoting monocytes/macrophages switch to an anti-inflammatory/pro-healing w/ IL-10 & reducing PMN/CTL infiltration @ARMI_Labs
https://t.co/0MZTluFXeW

[Nature Rev Immunol @NatRevImmunol]

Inflammasome components as new therapeutic targets in inflammatory disease https://t.co/gqBaNNZoDU

[Waggoner Lab @LabWaggoner]

Cancer stem cells produce large oncosomes that deliver IL-33 specifically to niche macrophage precursors, promoting the differentiation of these cells into an immune-suppressive phenotype @ImmunityCP
https://t.co/OTGj06wC9a

[Denis Wirtz @deniswirtz]

Macrophages are terrible at migrating. In contrast, their precursor cells - monocytes - are highly motile.

Monocytes exploit interleukin 6 (IL-6) secreted by cancer cells and themselves to migrate fast and promote cancer cell proliferation.

More here: https://t.co/r2uyQ2I6pB

[Mauricio Sousa @Maucostasousa]

@swimberly @uofldentistry @OIID_UL Congrats, Kim. Well deserved!

[AADOCR @AADOCR]

AADOCR strongly opposes the proposal to consolidate the existing 27 institutes and centers (ICs) of the @NIH into 15 newly renamed ICs. Read the statement:
https://t.co/McvCgXQuJu

[The Lancet @TheLancet]

Almost half of those living on our planet today are living in poverty.

In his latest Offline, Richard Horton calls for poverty reduction to be back at the centre of attention in the global health community.

Read this and more in our latest issue: https://t.co/v0Bi6l0QxM

[Cancer Cell @Cancer_Cell]

Online Now: Bacteria in metastatic sites: Unveiling hidden players in cancer progression https://t.co/RbKgGiwqL3

[Bioactive Materials @BioactiveMat]

Advanced biomedical and electronic dual-function skin patch created through microfluidic-regulated 3D bioprinting https://t.co/7cIqbdj7oe

[AADOCR @AADOCR]

Apply by May 10th to be part of Cohort 5 of the AADOCR MIND the Future Program! The program offers educational activities and interactive opportunities between mentors and mentees to support the development of a diverse cadre of DOC researchers.

https://t.co/uKyEVkbFm3

[AADOCR @AADOCR]

Apply to the MIND the Future Program! Be part of a network of mentors and mentees dedicated to supporting a diverse pool of young investigators in developing their careers in DOC research.

Apply by Friday, May 10th! #oralhealth #dentalresearch
https://t.co/zwcY9v2UCe

[Mauricio Sousa @Maucostasousa]

🔥F. nucleatum again

[Nature Microbiology @NatureMicrobiol]

OUT NOW in @CellCellPress👉A pan-cancer analysis of the microbiome in metastatic cancer

https://t.co/7NbNUKAtKf

[Eric Topol @EricTopol]

Bacteria in metastatic cancer tissue, mostly anaerobic and affected by anatomic site, predicts responsiveness to immunotherapy
https://t.co/rm8vqcMfy2 @CellCellPress

[Nature Medicine @NatureMedicine]

Immune checkpoint blockade plus a vaccine including self-amplifying mRNA-encoded neoantigens derived from common oncogenic driver mutations was safe and elicited neoantigen-specific T cell responses in patients with advanced solid tumors #CancerVaccine
https://t.co/CsqDQ381Zo